Watkins PB

References (3)

Title : Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease - Fontana_1998_Br.J.Clin.Pharmacol_46_221
Author(s) : Fontana RJ , deVries TM , Woolf TF , Knapp MJ , Brown AS , Kaminsky LS , Tang BK , Foster NL , Brown RR , Watkins PB
Ref : British Journal of Clinical Pharmacology , 46 :221 , 1998
Abstract :
PubMedSearch : Fontana_1998_Br.J.Clin.Pharmacol_46_221
PubMedID: 9764962

Title : The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicity - Fontana_1996_Hepatology_23_1429
Author(s) : Fontana RJ , Turgeon DK , Woolf TF , Knapp MJ , Foster NL , Watkins PB
Ref : Hepatology , 23 :1429 , 1996
Abstract :
PubMedSearch : Fontana_1996_Hepatology_23_1429
PubMedID: 8675160

Title : Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease - Watkins_1994_JAMA_271_992
Author(s) : Watkins PB , Zimmerman HJ , Knapp MJ , Gracon SI , Lewis KW
Ref : Jama , 271 :992 , 1994
Abstract :
PubMedSearch : Watkins_1994_JAMA_271_992
PubMedID: 8139084